State of Wisconsin Investment Board
FATE icon

State of Wisconsin Investment Board’s Fate Therapeutics FATE Stock Holding History

State of Wisconsin Investment Board’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-119,987
Closed -$571K – 2539
2023
Q2 		$571K Sell
119,987
-67,398
-36% -$372K ﹤0.01% 1761
2023
Q1 		$1.07M Buy
187,385
+92,779
+98% +$560K ﹤0.01% 1457
2022
Q4 		$955K Buy
94,606
+15,689
+20% +$295K ﹤0.01% 1521
2022
Q3 		$1.77M Sell
78,917
-3,870
-5% -$112K 0.01% 1369
2022
Q2 		$2.05M Sell
82,787
-25,913
-24% -$715K 0.01% 1355
2022
Q1 		$4.21M Hold
108,700
– – 0.01% 1225
2021
Q4 		$6.36M Buy
108,700
+6,200
+6% +$351K 0.01% 954
2021
Q3 		$6.08M Sell
102,500
-3,829
-4% -$300K 0.01% 973
2021
Q2 		$9.23M Sell
106,329
-271
-0.3% -$21.8K 0.02% 800
2021
Q1 		$8.79M Buy
106,600
+2,500
+2% +$240K 0.02% 797
2020
Q4 		$9.47M Buy
104,100
+3,600
+4% +$224K 0.02% 701
2020
Q3 		$4.02M Hold
100,500
– – 0.01% 1002
2020
Q2 		$3.45M Buy
100,500
+6,900
+7% +$206K 0.01% 993
2020
Q1 		$2.08M Buy
93,600
+4,600
+5% +$116K 0.01% 1057
2019
Q4 		$1.74M Hold
89,000
– – ﹤0.01% 1153
2019
Q3 		$1.38M Hold
89,000
– – ﹤0.01% 1078
2019
Q2 		$1.81M Buy
89,000
+2,000
+2% +$36K 0.01% 1036
2019
Q1 		$1.53M Buy
87,000
+35,100
+68% +$554K ﹤0.01% 1051
2018
Q4 		$666K Buy
51,900
+1,300
+3% +$18.1K ﹤0.01% 1245
2018
Q3 		$824K Hold
50,600
– – ﹤0.01% 1272
2018
Q2 		$574K Buy
50,600
+20,600
+69% +$227K ﹤0.01% 1327
2018
Q1 		$293K Hold
30,000
– – ﹤0.01% 1367
2017
Q4 		$183K Hold
30,000
– – ﹤0.01% 1392
2017
Q3 		$119K Hold
30,000
– – ﹤0.01% 1431
2017
Q2 		$97K Buy
+30,000
New +$115K ﹤0.01% 1446

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State of Wisconsin Investment Board's FATE Position: Q3 2023 in Review

State of Wisconsin Investment Board sold out of Fate Therapeutics (FATE) in Q3 2023, closing a stake of 119,987 shares — an estimated $571K sold.

State of Wisconsin Investment Board first reported a position in FATE in Q2 2017 and held it in 25 quarters. The position peaked at $9.47M in Q4 2020. 170 funds tracked by Wall St. Rank hold FATE as of Q3 2023.

  • State of Wisconsin Investment Board reported no remaining Fate Therapeutics position as of Q3 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 119,987 Fate Therapeutics shares in Q3 2023, an estimated $571K.
  • State of Wisconsin Investment Board first reported a position in Fate Therapeutics in Q2 2017 and held it in 25 quarters.
  • State of Wisconsin Investment Board's Fate Therapeutics position peaked at $9.47M in Q4 2020.
  • 170 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2023, filed 14 Nov 2023.